On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Amy Guisinger

ResearcherPublications, citations & collaboration network

Amy Guisinger is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Amy Guisinger have?

ScholarIQindexed works

Amy Guisinger has 14 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Amy Guisinger have?

ScholarIQcitation count

Amy Guisinger has 129 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Amy Guisinger?

ScholarIQh-index

Amy Guisinger has an h-index of 4 in OpenAlex.

What is the i10-index of Amy Guisinger?

ScholarIQi10-index

Amy Guisinger has an i10-index of 4 in OpenAlex.

What is the ORCID of Amy Guisinger?

ScholarIQorcid

The ORCID for Amy Guisinger is on the source record.

What is the OpenAlex record for Amy Guisinger?

ScholarIQopenalex

The OpenAlex for Amy Guisinger is on the source record.

What are the most-cited papers on Amy Guisinger?

ScholarIQmost cited works
Screening for Vitamin D Deficiency in Adults
Leila C. Kahwati, Erin S. LeBlanc, Rachel Palmieri Weber, Kayla Giger, Rachel Clark, Kara Suvada, Amy Guisinger, Meera Viswanathan
JAMA. 202172 Citations
Assessment of Study Quality
Leila C. Kahwati, Erin S. LeBlanc, Rachel Palmieri Weber, Kayla Giger, Rachel M. Clark, Kara Suvada, Amy Guisinger, Meera Viswanathan
202129 Citations
<p>Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy</p>
Chad Moretz, Ashley L. Cole, George Mu, Benjamin Wu, Amy Guisinger, Yunhao Liu, Beth Hahn, Lee Baylis
International Journal of COPD. 202013 CitationsOPEN ACCESS
Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study
Shirley P. Huang, Amy Guisinger, Carlyne M. Averell, Christopher F. Bell, Bernie Rubin
Rheumatology and Therapy. 202310 CitationsOPEN ACCESS
Abstract PS13-33: Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan
Heather Moore, Scott Shofer, Amy Guisinger, Gloria Broadwater, Jeremy Force, Sarah Sammons, Carey K. Anders, Kelly Westbrook
Cancer Research. 20213 Citations

Related on ScholarIQ

470M+ articles · 14-day free trial